About Bioquell plc (LON:BQE)
Bioquell Plc is engaged in the design, manufacture and supply of bio-decontamination and containment equipment, related products and services to the pharmaceutical, healthcare, food and defense industries, and testing services to the aerospace, telecoms, defense and other industries. The Company's operating segment is Bio-decontamination (BIO). The Company offers various products, which include Healthcare products, such as Healthcare HP Vapor Services, Healthcare HP Vapor Generators, Healthcare Patient Rooms, Healthcare Pharmacy Workstation, Healthcare Consumables/Accessories and Healthcare Archived Products; Life Science products, such as Life Sciences Aseptic Workstation, Life Sciences HP Vapor Services, Life Sciences Materials Transfer, Life Sciences HP Vapor Generators, Life Sciences Consumables/Accessories and Archived Products, and Defense products, such as Defense CBRN Filtration, Controls, Defense Pre-filtration, and Defense Consumables and Spares.
Industry, Sector and Symbol:
- Industry: Medical Equipment, Supplies & Distribution
- Sub-Industry: N/A
- Sector: Medical Equipment, Supplies & Distribution - NEC
- Symbol: LON:BQE
- CUSIP: N/A
- Web: www.bioquellplc.com
- Trailing EPS: GBX 0.05
- Net Margins: 8.54%
- Return on Equity: 9.99%
- Return on Assets: 7.80%
- Outstanding Shares: 22,450,000
Frequently Asked Questions for Bioquell plc (LON:BQE)
What is Bioquell plc's stock symbol?
Bioquell plc trades on the London Stock Exchange (LON) under the ticker symbol "BQE."
Who are some of Bioquell plc's key competitors?
Some companies that are related to Bioquell plc include Tandem Diabetes Care (TNDM), Surgical Innovations Group plc (SUN), Capnia (SLNO), Cytori Therapeutics (CYTX), Alliqua BioMedical (ALQA), Lombard Medical (EVARF), NeuroMetrix (NURO), InspireMD (NSPR), Great Basin Scientific (GBSN), Asante Solutions (PUMP), LDR Holding Corp (LDRH) and Symmetry Medical (SMA).
Who are Bioquell plc's key executives?
Bioquell plc's management team includes the folowing people:
- Nicholas M. T. Adams, Chief Executive, Executive Director
- Michael R. D. Roller, Group Finance Director, Executive Director (Age 49)
- Georgina Pope, Company Secretary
- Ian Roy Johnson, Non-Executive Chairman of the Board (Age 63)
- Ian Carruthers OBE, Independent Non-Executive Director
- Simon John Constantine, Independent Non-Executive Director (Age 55)
- Christopher Harwood Bernard Mills, Independent Non-Executive Director (Age 64)
How do I buy Bioquell plc stock?
Shares of Bioquell plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Bioquell plc's stock price today?
One share of Bioquell plc stock can currently be purchased for approximately GBX 256.60.
How big of a company is Bioquell plc?
Bioquell plc has a market capitalization of £55.62 million.
How can I contact Bioquell plc?
Bioquell plc's mailing address is West Portway, 52 Royce Close, ANDOVER, SP10 3TS, United Kingdom. The company can be reached via phone at +44-1264-835900.
MarketBeat Community Rating for Bioquell plc (LON BQE)MarketBeat's community ratings are surveys of what our community members think about Bioquell plc and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Analysts' Consensus Rating for Bioquell plc (LON:BQE) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||0 Sell Ratings, 0 Hold Ratings, 0 Buy Ratings, 0 Strong Buy RatingsNo ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Analysts' Consensus Price Target: ||N/A|
Consensus Price Target History for Bioquell plc (LON:BQE)
Analysts' Ratings History for Bioquell plc (LON:BQE)
(Data available from 11/20/2015 forward)
|3/7/2017||N+1 Singer||Reiterated Rating||Corporate|
Earnings History for Bioquell plc (LON:BQE)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Bioquell plc (LON:BQE)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History by Quarter for Bioquell plc (LON BQE)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading and Institutional Ownership History for Bioquell plc (LON BQE)
Insider Trades by Quarter for Bioquell plc (LON BQE)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|8/22/2017||Georgina Pope||Insider||Sell||2,500||GBX 260||£6,500|
|5/17/2017||Michael R D Roller||Insider||Buy||13,381||GBX 159||£21,275.79|
|4/5/2017||Michael R D Roller||Insider||Buy||19,000||GBX 148||£28,120|
Latest Headlines for Bioquell plc (LON BQE)
Financials are not available for this stock.
Bioquell plc (LON BQE) Chart for Monday, November, 20, 2017